Intervention
therapeutic conventional surgery
ClinicalTrials.gov intervention label
Clinical trials
60 shownIntensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast CancerNCT02186470 · 2016-04-29
COMPLETEDPegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast CancerNCT02315196 · 2015-02-25
ACTIVE_NOT_RECRUITINGStereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung CancerNCT02250378 · 2014-10-01
WITHDRAWNPhotodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyNCT02106559 · 2014-09-04
WITHDRAWNEffect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing SurgeryNCT01912820 · 2014-01-01
COMPLETEDOral CDB-4124 vs. Placebo in Stage I-II Primary Breast CancerNCT01800422 · 2013-06-01
UNKNOWNVorinostat Before Surgery in Treating Patients With Triple-Negative Breast CancerNCT01695057 · 2012-10-01
WITHDRAWNBiomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidNCT01409811 · 2012-09-14
TERMINATEDBreast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast CancerNCT01556243 · 2012-07-01
COMPLETEDLapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast CancerNCT01688609 · 2012-07-01
COMPLETEDAxitinib Before Surgery in Treating Patients With High-Risk Prostate CancerNCT01385059 · 2011-10-28
COMPLETEDNeo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerNCT01394211 · 2011-07-13
TERMINATEDEarly Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerNCT01242800 · 2011-05-16
COMPLETEDSurgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung CancerNCT01336894 · 2011-05-01
TERMINATEDGenistein in Treating Patients With Prostate CancerNCT01126879 · 2011-02-03
TERMINATEDAzacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryNCT01292083 · 2011-01-01
WITHDRAWNMagnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate CancerNCT01764347 · 2010-11-01
COMPLETEDRO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerNCT01208441 · 2010-11-01
TERMINATEDEntinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryNCT01234532 · 2010-10-01
TERMINATEDTargeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing SurgeryNCT01147016 · 2010-07-01
TERMINATEDRitonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerNCT01009437 · 2010-05-26
COMPLETEDTrastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast CancerNCT01104571 · 2010-04-01
UNKNOWNBreast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast CancerNCT01100489 · 2010-02-01
WITHDRAWNProton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryNCT01076231 · 2010-01-01
COMPLETEDDoxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast CancerNCT00994968 · 2009-07-01
UNKNOWNSurgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00881361 · 2009-07-01
COMPLETEDVorinostat in Treating Women With Ductal Carcinoma in Situ of the BreastNCT00788112 · 2009-07-01
COMPLETEDRiluzole in Women With Stage I, Stage II, or Stage IIIA Breast CancerNCT00903214 · 2009-05-01
WITHDRAWNCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast CancerNCT01093235 · 2009-04-01
UNKNOWNPain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast CancerNCT00859157 · 2008-10-01
COMPLETEDCryoablation Therapy in Treating Patients With Invasive Ductal Breast CancerNCT00723294 · 2008-09-01
UNKNOWNHypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast CancerNCT00748267 · 2008-08-01
COMPLETEDFludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryNCT00732563 · 2008-07-16
COMPLETEDEverolimus in Treating Women With Breast Cancer That Can Be Removed by SurgeryNCT00855114 · 2008-07-01
WITHDRAWNTrastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By SurgeryNCT00674414 · 2008-04-01
TERMINATEDMeasuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the BreastNCT00665782 · 2008-03-01
COMPLETEDLycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate CancerNCT00450749 · 2008-02-01
COMPLETEDDoxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing SurgeryNCT00671476 · 2008-02-01
UNKNOWNCarboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingNCT00618657 · 2008-02-01
COMPLETEDEffects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing ProstatectomyNCT01009736 · 2008-01-01
COMPLETEDGenetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryNCT00977457 · 2007-11-26
ACTIVE_NOT_RECRUITINGStereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerNCT01068327 · 2007-11-05
COMPLETEDRadiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastNCT00602628 · 2007-11-01
COMPLETEDSunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerNCT00513695 · 2007-06-01
COMPLETEDRadiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast CancerNCT00872625 · 2007-04-01
COMPLETEDBreast-Conserving Surgery Techniques in Treating Women With Breast CancerNCT00870415 · 2007-04-01
COMPLETEDDiindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate CancerNCT00450229 · 2007-02-01
COMPLETEDSorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate CancerNCT00466752 · 2006-12-01
COMPLETEDPositron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerNCT01254591 · 2006-11-01
UNKNOWNGefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung CancerNCT00616499 · 2006-11-01
UNKNOWNDefined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryNCT01340599 · 2006-10-01
TERMINATEDOptical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast TumorsNCT00625417 · 2006-08-01
COMPLETEDLoop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral ResectionNCT00303654 · 2005-08-01
COMPLETEDHormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerNCT00194792 · 2005-08-01
TERMINATEDPositron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNCT00227539 · 2005-07-01
COMPLETEDPhotodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the PleuraNCT00601848 · 2004-11-01
TERMINATEDDeslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseNCT00080756 · 2004-03-11
UNKNOWNCombination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryNCT00194779 · 2003-10-01
COMPLETEDOblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerNCT00063934 · 2003-05-01
TERMINATEDCelecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerNCT00070057 · 2003-04-01
COMPLETEDCommon conditions
Breast Cancer28Stage IIIA Breast Cancer15Stage II Breast Cancer14Stage IIIB Breast Cancer9Estrogen Receptor-positive Breast Cancer7Lung Cancer7Stage IIIC Breast Cancer7HER2-negative Breast Cancer6Progesterone Receptor-positive Breast Cancer6Stage IA Breast Cancer6Stage IB Breast Cancer6Adenocarcinoma of the Prostate5Stage I Prostate Cancer5Stage III Prostate Cancer5Estrogen Receptor-negative Breast Cancer4HER2-positive Breast Cancer4Male Breast Cancer4Progesterone Receptor-negative Breast Cancer4Prostate Cancer4Stage I Breast Cancer4Stage II Prostate Cancer4Stage IV Breast Cancer4Triple-negative Breast Cancer4Inflammatory Breast Cancer3Invasive Ductal Breast Carcinoma3
Leading sponsors
National Cancer Institute (NCI)10Alliance for Clinical Trials in Oncology5City of Hope Medical Center5University of Washington5University of Southern California4Ohio State University Comprehensive Cancer Center3Abramson Cancer Center at Penn Medicine2Barbara Ann Karmanos Cancer Institute2Case Comprehensive Cancer Center2Masonic Cancer Center, University of Minnesota2Mayo Clinic2Northwestern University2Vanderbilt-Ingram Cancer Center2Yonsei University2Cambridge University Hospitals NHS Foundation Trust1
Trial status mix
COMPLETED38
TERMINATED14
UNKNOWN9
WITHDRAWN7
ACTIVE_NOT_RECRUITING2
Phase mix
PHASE234
NA17
PHASE113
PHASE37
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.